K. Rene Ward
Associate Director, Public Relations and Internal Communications
3902 Gene Field Road
St. Joseph, Missouri 64506
Prevention Works sets tone for future of cattle division
You can’t afford to leave dollars on the table, especially in today’s competitive market. Progressive producers know healthy animals cost less to maintain and can be more productive in the long run. Why? Because history has proved how powerful disease prevention can be.
Boehringer Ingelheim Vetmedica, Inc. believes helping to prevent disease is a more effective way to maintain animal health than simply treating diseases as they arise. “This year, Boehringer Ingelheim Vetmedica, Inc. cattle division embarks on a new path. We are making a commitment to be focused on disease prevention, because Prevention Works,” says Colin Meyers, Executive Director, U.S. Cattle Business and Process Excellence at Boehringer Ingelheim Vetmedica, Inc.
“In the production animal side of the business, we understand that preventing diseases is the absolute, best thing we can do. And that is for the animal’s well-being, certainly looking at it from our customer’s perspective, and most importantly, looking at it from the consumer’s perspective,” Meyers says.
Meat and milk producers are more focused than ever on meeting the changing demands of consumers while being good animal caretakers.
The Prevention Works initiative shows Boehringer Ingelheim Vetmedica, Inc.'s commitment to helping producers meet this objective and turn a healthy profit.
“Regardless if you’re a beef producer or a dairy producer, prevention just makes sense. If I can prevent disease in the long run, you can make more money. The goal for any herd, ultimately, should be to prevent disease” says Dr. Craig Jones, Senior Associate Director, Cattle Professional Services with Boehringer Ingelheim Vetmedica, Inc.
Boehringer Ingelheim Vetmedica, Inc. cattle division has incorporated, and will continue to incorporate, the Prevention Works philosophy into all areas of its business. With a recently completed expansion of its biological manufacturing facility and a renewed commitment to research and development, Boehringer Ingelheim Vetmedica, Inc. is poised for a strong future. The company continues to explore new opportunities to work with beef and dairy veterinarians and their clients.
For more information on Prevention Works, please visit www.BIVIPreventionWorks.com or visit with your local veterinarian or Boehringer Ingelheim Vetmedica, Inc. cattle representative.
Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, MO), is a subsidiary of Boehringer Ingelheim Corporation based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
For Boehringer Ingelheim—and its employees—carrying a good share of social responsibility is an important component in its business culture. Both global commitments in social projects and properly caring for all its employees are included. Respect, equal opportunity, and the balance of career and family life form the basis for mutual cooperation. And, environmental protection and sustainability are always the main focus during any of Boehringer Ingelheim’s undertakings.
In 2010, Boehringer Ingelheim posted net sales of approximately $16.7 billion (about 12.6 billion euro) while spending almost 24% of net sales in its largest business segment, Prescription Medicines, on research and development.
For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.